Literature DB >> 3516457

Patients with coeliac disease have a characteristic gliadin antibody pattern.

S U Friis, O Norén, H Sjöström, E Gudmand-Høyer.   

Abstract

By use of an immunoblotting technique we have investigated the specificity of circulating IgG antibodies with respect to reactions with the alpha-, beta-, gamma- and omega-fractions of gliadin in patients with coeliac disease and in patients with diarrhoea of other causes. Untreated coeliac patients show a characteristic reactivity against polypeptides in the gamma-fraction, with an Mr of 35 and 45 kilodaltons, but only minor reactivity against the other fractions. One coeliac patient exclusively had antibodies to a 80 kilodalton component. Such a reaction pattern was not observed in other groups of patients with diarrhoea, as they had only weak reactions against the gamma-fraction but a stronger reaction against the other fractions. This might indicate that enterocytes of coeliac patients specifically take up distinct polypeptides of gamma-gliadin and by transcellular transport present them to immunocompetent cells. The results also suggest that there are distinct components of gliadin that provoke symptoms in different coeliac patients, indicating a heterogenecity of the disease. The study might lead to new diagnostic methods and to elucidation of the pathogenetic mechanisms behind coeliac disease.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3516457     DOI: 10.1016/0009-8981(86)90274-3

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  4 in total

1.  The measurement of respiratory burst induced in polymorphonuclear neutrophils by IgA and IgG anti-gliadin antibodies isolated from coeliac serum.

Authors:  W W Stewart; M A Kerr
Journal:  Immunology       Date:  1991-08       Impact factor: 7.397

2.  Anti-gliadin antibody specificity for gluten-derived peptides toxic to coeliac patients.

Authors:  J M Devery; J T La Brooy; S Krillis; G Davidson; J H Skerritt
Journal:  Clin Exp Immunol       Date:  1989-06       Impact factor: 4.330

3.  Gliadin uptake in human enterocytes. Differences between coeliac patients in remission and control individuals.

Authors:  S Friis; E Dabelsteen; H Sjöström; O Norén; S Jarnum
Journal:  Gut       Date:  1992-11       Impact factor: 23.059

4.  Gliadin-specific, HLA-DQ(alpha 1*0501,beta 1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients.

Authors:  K E Lundin; H Scott; T Hansen; G Paulsen; T S Halstensen; O Fausa; E Thorsby; L M Sollid
Journal:  J Exp Med       Date:  1993-07-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.